Metabolite Identification Study

Metabolite identification study characterises drug biotransformation products employing mass spectrometry and NMR. Radioactive labelling tracks drug fate. Metabolite structural elucidation guides toxicity assessment. Active metabolite identification informs pharmacology. Regulatory submissions include comprehensive metabolite characterisation.

Metabolite toxicity assessment determines whether testing requirements apply. Pharmacokinetic metabolite modeling predicts plasma concentrations. Bioanalytical methods quantitate parent drug and metabolites. Post-approval monitoring detects unexpected metabolites. Emerging metabolomics unbiasedly identifies metabolites.